| Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial Y Shieh, M Eklund, L Madlensky, SD Sawyer, CK Thompson, ... Journal of the National Cancer Institute 109 (5), djw290, 2017 | 220 | 2017 |
| A role for common genomic variants in the assessment of familial breast cancer S Sawyer, G Mitchell, J McKinley, G Chenevix-Trench, J Beesley, ... Journal of clinical oncology 30 (35), 4330-4336, 2012 | 104 | 2012 |
| Analysis of RAD51C germline mutations in high‐risk breast and ovarian cancer families and ovarian cancer patients ER Thompson, SE Boyle, J Johnson, GL Ryland, S Sawyer, DYH Choong, ... Human mutation 33 (1), 95-99, 2012 | 91 | 2012 |
| Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in … M Magbanua, L Brown-Swigart, G Hirst, C Yau, D Wolf, A Ma, E Bergin, ... Data presented at spotlight session: San Antonio Breast Cancer Symposium, 2018 | 69 | 2018 |
| A polygenic risk score for breast cancer in US Latinas and Latin American women Y Shieh, L Fejerman, PC Lott, K Marker, SD Sawyer, D Hu, S Huntsman, ... JNCI: Journal of the National Cancer Institute 112 (6), 590-598, 2020 | 63 | 2020 |
| Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer ER Thompson, SM Rowley, S Sawyer, DM Eccles, AH Trainer, G Mitchell, ... PloS one 8 (1), e54772, 2013 | 52 | 2013 |
| Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy SK Warrier, AH Trainer, AC Lynch, C Mitchell, R Hiscock, S Sawyer, ... Diseases of the colon & rectum 54 (12), 1480-1487, 2011 | 41 | 2011 |
| Making sense of SNPs: women’s understanding and experiences of receiving a personalized profile of their breast cancer risks MA Young, LE Forrest, VM Rasmussen, P James, G Mitchell, SD Sawyer, ... Journal of Genetic Counseling 27, 702-708, 2018 | 35 | 2018 |
| Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features PA James, S Sawyer, S Boyle, MA Young, S Kovalenko, R Doherty, ... Familial cancer 14, 287-295, 2015 | 30 | 2015 |
| High-risk women’s risk perception after receiving personalized polygenic breast cancer risk information LE Forrest, SD Sawyer, N Hallowell, PA James, MA Young Journal of Community Genetics 10, 197-206, 2019 | 27 | 2019 |
| Tumour morphology predicts PALB2 germline mutation status ZL Teo, E Provenzano, GS Dite, DJ Park, C Apicella, SD Sawyer, ... British journal of cancer 109 (1), 154-163, 2013 | 27 | 2013 |
| Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer JY Hou, JS Chapman, E Kalashnikova, W Pierson, K Smith-McCune, ... Gynecologic Oncology 167 (2), 334-341, 2022 | 22 | 2022 |
| BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer PM Kasi, S Sawyer, J Guilford, M Munro, S Ellers, J Wulff, N Hook, ... BMJ open 11 (9), e047831, 2021 | 22 | 2021 |
| The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia ZL Teo, SD Sawyer, PA James, G Mitchell, AH Trainer, GJ Lindeman, ... Familial Cancer 12, 587-595, 2013 | 16 | 2013 |
| BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours PM Kasi, S Chakrabarti, S Sawyer, M Krainock, A Poklepovic, G Ansstas, ... BMJ open 12 (5), e060342, 2022 | 4 | 2022 |
| Circulating tumor DNA predicts disease recurrence in ovarian cancer patients JS Chapman, WE Pierson, K Smith-McCune, G Pineda, RM Vattakalam, ... Cancer Research 81 (13_Supplement), 552-552, 2021 | 2 | 2021 |
| 520TiP A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer PM Kasi, S Sawyer, J Guilford, M Munro, S Ellers, N Hook, S Krinshpun, ... Annals of Oncology 31, S459, 2020 | 2 | 2020 |
| The WISDOM study pilot: Evaluating a preference-tolerant RCT of risk-based vs. annual breast cancer screening. S Theiner, C Kaplan, S Sarrafan, J Cabrera, SD Sawyer, AS Liang, ... Journal of Clinical Oncology 34 (15_suppl), e13035-e13035, 2016 | 2 | 2016 |
| Abstract P2-10-05: A breast cancer multi-racial/ethnic polygenic risk score for improved personalized breast cancer screening S Theiner, D Hu, S Huntsman, Y Shieh, L Fejerman, I Acerbi, SD Sawyer, ... Cancer Research 80 (4_Supplement), P2-10-05-P2-10-05, 2020 | 1 | 2020 |
| A polygenic risk score predicts breast cancer risk in Latinas Y Shieh, L Fejerman, SD Sawyer, D Hu, S Huntsman, EM John, LH Kushi, ... Cancer Research 79 (13_Supplement), 2419-2419, 2019 | 1 | 2019 |
